Stay current with MiRXES
Newsroom > Media Releases
MiRXES’s Founders Named EY Entrepreneur Of The Year 2021 Singapore
SINGAPORE, 22 November 2021 – MiRXES Pte Ltd, a Singapore-headquartered biotechnology company focused on improving and saving lives with RNA-powered disease early detection tests, announced today that Dr. Lihan ZHOU, Co-founder and Chief Executive Officer at MiRXES, Dr. Ruiyang ZOU, Co-founder and Chief Technology Officer at MiRXES and Mr. Isaac HO, Chief Investment Officer at MiRXES, have been named EY Entrepreneur Of The Year (EOY) 2021 Singapore by professional services organization, EY.
“It is a great honor to be named Singapore’s overall winner of the prestigious EY Entrepreneur Of The YearTM 2021. We are thankful to the judges for having trust and confidence in my co-founders’ and my entrepreneurship and leadership qualities as this achievement is a validation of MiRXES team’s decade long journey to develop novel RNA technologies and to anchor RNA diagnostics development infrastructures in Singapore,” said Dr. Zhou. “This award belongs to the entire MiRXES family which has shown dedication, resilience and agility especially for the past 22 months as we remain strong as One Team during these unprecedented times. We hope that winning this award can raise the awareness of RNA diagnostics, cancer screening and preventive healthcare, and everyone will be more proactive in managing their health.”
MiRXES’s co-founders went through an intensive selection process by an independent judging panel, where the judges assessed them based on entrepreneurial spirit, financial performance/value creation, strategic direction, national and global impact, innovation and personal integrity/purpose-driven leadership. MiRXES received this award at the EY EOY Awards celebration from the guest-of-honor, Ms. Indranee Rajah, Minister for Prime Minister’s Office, Second Minister for Finance and Second Minister for National Development, and will represent Singapore at the annual EY World Entrepreneur Of The Year (WEOY) award in 2022 to compete with contenders from over 60 jurisdictions.